as 07-26-2024 4:00pm EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | CINCINNATI |
Market Cap: | 8.1B | IPO Year: | N/A |
Target Price: | $673.50 | AVG Volume (30 days): | 110.6K |
Analyst Decision: | Buy | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 18.59 | EPS Growth: | 17.07 |
52 Week Low/High: | $492.84 - $654.62 | Next Earning Date: | 07-24-2024 |
Revenue: | $2,293,493,000 | Revenue Growth: | 5.96% |
Revenue Growth (this year): | 8.37% | Revenue Growth (next year): | 6.76% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
GRACE PATRICK P | CHE | Director | Jun 12 '24 | Sell | $540.98 | 284 | $153,638.32 | 3,270 | SEC Form 4 |
MCNAMARA KEVIN J | CHE | president and CEO | Jun 6 '24 | Sell | $544.17 | 1,500 | $816,255.00 | 107,049 | SEC Form 4 |
MCNAMARA KEVIN J | CHE | president and CEO | May 16 '24 | Sell | $567.54 | 4,000 | $2,270,160.00 | 108,549 | SEC Form 4 |
LEE SPENCER S | CHE | executive vice president | Mar 28 '24 | Sell | $641.65 | 2,000 | $1,283,300.00 | 20,760 | SEC Form 4 |
Witzeman Michael D | CHE | VP & Chief Financial Officer | Mar 20 '24 | Sell | $643.14 | 2,650 | $1,704,321.00 | 2,882 | SEC Form 4 |
Judkins Brian C | CHE | VP and Chief Legal Officer | Mar 20 '24 | Sell | $645.00 | 11,158 | $7,196,910.00 | 1,422 | SEC Form 4 |
MCNAMARA KEVIN J | CHE | president and CEO | Dec 11 '23 | Sell | $572.77 | 1,500 | $859,155.00 | 111,468 | SEC Form 4 |
LEE SPENCER S | CHE | executive vice president | Nov 27 '23 | Sell | $579.73 | 1,000 | $579,730.00 | 22,568 | SEC Form 4 |
WILLIAMS DAVID PATRICK | CHE | executive vice president & CFO | Nov 13 '23 | Sell | $586.32 | 3,814 | $2,236,224.48 | 7,012 | SEC Form 4 |
WILLIAMS DAVID PATRICK | CHE | executive vice president & CFO | Nov 13 '23 | Sell | $586.08 | 1,186 | $695,090.88 | 5,826 | SEC Form 4 |
LEE SPENCER S | CHE | executive vice president | Nov 7 '23 | Sell | $583.85 | 1,217 | $710,545.45 | 23,633 | SEC Form 4 |
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
18 hours ago
Zacks
2 days ago
Zacks
2 days ago
MT Newswires
2 days ago
Associated Press Finance
2 days ago
Business Wire
2 days ago
Argus Research
3 days ago
Simply Wall St.
7 days ago
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.